GBT
PTCT icon

Grove Bank & Trust’s PTC Therapeutics PTCT Stock Holding History

Grove Bank & Trust’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-18
Closed -$403 – 680
2023
Q3 		$403 Buy
+18
New +$669 ﹤0.01% 732

Other funds holding PTCT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Grove Bank & Trust's PTCT Position: Q4 2023 in Review

Grove Bank & Trust sold out of PTC Therapeutics (PTCT) in Q4 2023, closing a stake of 18 shares — an estimated $403 sold.

Grove Bank & Trust first reported a position in PTCT in Q3 2023 and held it in 1 quarter. The position peaked at $403 in Q3 2023. 172 funds tracked by Wall St. Rank hold PTCT as of Q4 2023.

  • Grove Bank & Trust reported no remaining PTC Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Grove Bank & Trust sold 18 PTC Therapeutics shares in Q4 2023, an estimated $403.
  • Grove Bank & Trust first reported a position in PTC Therapeutics in Q3 2023 and held it in 1 quarter.
  • Grove Bank & Trust's PTC Therapeutics position peaked at $403 in Q3 2023.
  • 172 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2023.

Based on Grove Bank & Trust's 13F filing for Q4 2023, filed 30 Jan 2024.